AAPL332.41+1.07 (+0.32%) ▲|ABBV262.51-0.53 (-0.20%) ▼|ABT102.36+0.33 (+0.32%) ▲|ACN189.64-3.76 (-1.94%) ▼|ADBE250.50-7.26 (-2.82%) ▼|AMAT415.38-5.79 (-1.37%) ▼|AMD512.50+8.30 (+1.65%) ▲|AMGN376.35+0.70 (+0.19%) ▲|AMT176.39-1.32 (-0.74%) ▼|AMZN245.96-2.46 (-0.99%) ▼|AVGO339.51+0.24 (+0.07%) ▲|AXP312.43-12.00 (-3.70%) ▼|BA201.96-7.73 (-3.69%) ▼|BAC57.90-1.62 (-2.72%) ▼|BKNG171.40+0.08 (+0.05%) ▲|BLK1,037.24-21.42 (-2.02%) ▼|BMY63.60-0.13 (-0.20%) ▼|BNY153.47-1.20 (-0.78%) ▼|BRK-B519.80+3.04 (+0.59%) ▲|C132.95-3.22 (-2.36%) ▼|CAT782.72-0.82 (-0.10%) ▼|CL87.02+0.02 (+0.02%) ▲|CMCSA23.73-0.69 (-2.83%) ▼|COF203.19-3.66 (-1.77%) ▼|COP132.54-8.68 (-6.15%) ▼|COST893.74-7.61 (-0.84%) ▼|CRM250.54-5.11 (-2.00%) ▼|CSCO107.74-2.33 (-2.12%) ▼|CVS91.72-2.77 (-2.93%) ▼|CVX211.54-6.23 (-2.86%) ▼|DE669.47-14.57 (-2.13%) ▼|DHR208.36-1.00 (-0.48%) ▼|DIS106.99+0.57 (+0.54%) ▲|DUK117.76-0.01 (-0.01%) ▼|EMR145.83-1.17 (-0.80%) ▼|FDX301.72-6.54 (-2.12%) ▼|GD360.00+1.40 (+0.39%) ▲|GE312.90+5.85 (+1.91%) ▲|GEV925.09+42.28 (+4.79%) ▲|GILD147.68+1.38 (+0.94%) ▲|GM84.29-1.08 (-1.27%) ▼|GOOG339.36-2.07 (-0.61%) ▼|GOOGL342.87-2.11 (-0.61%) ▼|GS937.98-38.69 (-3.96%) ▼|HD302.47-3.01 (-0.99%) ▼|HON207.66+4.22 (+2.07%) ▲|IBM237.49-10.88 (-4.38%) ▼|INTC101.05+3.91 (+4.03%) ▲|INTU318.13-11.14 (-3.38%) ▼|ISRG382.29+5.13 (+1.36%) ▲|JNJ267.28+0.08 (+0.03%) ▲|JPM348.92-3.57 (-1.01%) ▼|KO87.87-0.84 (-0.95%) ▼|LIN462.09-0.87 (-0.19%) ▼|LLY1,137.82+1.71 (+0.15%) ▲|LMT537.25+3.79 (+0.71%) ▲|LOW194.10-0.51 (-0.26%) ▼|LRCX269.23-1.64 (-0.61%) ▼|MA567.75-5.52 (-0.96%) ▼|MCD248.56-4.22 (-1.67%) ▼|MDLZ62.36+0.26 (+0.42%) ▲|MDT92.60-1.15 (-1.23%) ▼|META673.31+3.07 (+0.46%) ▲|MMM162.65-2.02 (-1.23%) ▼|MO70.10+0.29 (+0.42%) ▲|MRK144.91+1.12 (+0.78%) ▲|MS202.42-3.86 (-1.87%) ▼|MSFT490.30-6.82 (-1.37%) ▼|MU926.55-1.05 (-0.11%) ▼|NEE80.37-0.70 (-0.86%) ▼|NFLX76.41-1.49 (-1.91%) ▼|NKE35.78-0.44 (-1.21%) ▼|NOW139.82-2.08 (-1.47%) ▼|NVDA213.90+1.73 (+0.82%) ▲|ORCL143.16+2.81 (+2.00%) ▲|PEP134.34-1.16 (-0.86%) ▼|PFE27.46-0.09 (-0.33%) ▼|PG147.02+0.35 (+0.24%) ▲|PLTR174.34+1.78 (+1.03%) ▲|PM191.71-2.40 (-1.24%) ▼|QCOM184.84-2.96 (-1.58%) ▼|RTX196.83+1.33 (+0.68%) ▲|SBUX97.34+0.76 (+0.79%) ▲|SCHW105.16-2.63 (-2.44%) ▼|SO86.23+0.28 (+0.33%) ▲|SPG202.94-1.16 (-0.57%) ▼|T25.86-0.86 (-3.22%) ▼|TMO648.43+7.04 (+1.10%) ▲|TMUS176.26-4.21 (-2.33%) ▼|TSLA358.08+1.50 (+0.42%) ▲|TXN260.67-2.76 (-1.05%) ▼|UBER70.97-0.46 (-0.64%) ▼|UNH375.26-0.67 (-0.18%) ▼|UNP280.92-3.07 (-1.08%) ▼|UPS98.77-3.58 (-3.50%) ▼|USB59.73-2.49 (-4.00%) ▼|V370.93-4.69 (-1.25%) ▼|VZ49.76-1.69 (-3.28%) ▼|WFC87.05-2.67 (-2.98%) ▼|WMT107.50-0.59 (-0.55%) ▼|XOM163.32-6.00 (-3.54%) ▼|AAPL332.41+1.07 (+0.32%) ▲|ABBV262.51-0.53 (-0.20%) ▼|ABT102.36+0.33 (+0.32%) ▲|ACN189.64-3.76 (-1.94%) ▼|ADBE250.50-7.26 (-2.82%) ▼|AMAT415.38-5.79 (-1.37%) ▼|AMD512.50+8.30 (+1.65%) ▲|AMGN376.35+0.70 (+0.19%) ▲|AMT176.39-1.32 (-0.74%) ▼|AMZN245.96-2.46 (-0.99%) ▼|AVGO339.51+0.24 (+0.07%) ▲|AXP312.43-12.00 (-3.70%) ▼|BA201.96-7.73 (-3.69%) ▼|BAC57.90-1.62 (-2.72%) ▼|BKNG171.40+0.08 (+0.05%) ▲|BLK1,037.24-21.42 (-2.02%) ▼|BMY63.60-0.13 (-0.20%) ▼|BNY153.47-1.20 (-0.78%) ▼|BRK-B519.80+3.04 (+0.59%) ▲|C132.95-3.22 (-2.36%) ▼|CAT782.72-0.82 (-0.10%) ▼|CL87.02+0.02 (+0.02%) ▲|CMCSA23.73-0.69 (-2.83%) ▼|COF203.19-3.66 (-1.77%) ▼|COP132.54-8.68 (-6.15%) ▼|COST893.74-7.61 (-0.84%) ▼|CRM250.54-5.11 (-2.00%) ▼|CSCO107.74-2.33 (-2.12%) ▼|CVS91.72-2.77 (-2.93%) ▼|CVX211.54-6.23 (-2.86%) ▼|DE669.47-14.57 (-2.13%) ▼|DHR208.36-1.00 (-0.48%) ▼|DIS106.99+0.57 (+0.54%) ▲|DUK117.76-0.01 (-0.01%) ▼|EMR145.83-1.17 (-0.80%) ▼|FDX301.72-6.54 (-2.12%) ▼|GD360.00+1.40 (+0.39%) ▲|GE312.90+5.85 (+1.91%) ▲|GEV925.09+42.28 (+4.79%) ▲|GILD147.68+1.38 (+0.94%) ▲|GM84.29-1.08 (-1.27%) ▼|GOOG339.36-2.07 (-0.61%) ▼|GOOGL342.87-2.11 (-0.61%) ▼|GS937.98-38.69 (-3.96%) ▼|HD302.47-3.01 (-0.99%) ▼|HON207.66+4.22 (+2.07%) ▲|IBM237.49-10.88 (-4.38%) ▼|INTC101.05+3.91 (+4.03%) ▲|INTU318.13-11.14 (-3.38%) ▼|ISRG382.29+5.13 (+1.36%) ▲|JNJ267.28+0.08 (+0.03%) ▲|JPM348.92-3.57 (-1.01%) ▼|KO87.87-0.84 (-0.95%) ▼|LIN462.09-0.87 (-0.19%) ▼|LLY1,137.82+1.71 (+0.15%) ▲|LMT537.25+3.79 (+0.71%) ▲|LOW194.10-0.51 (-0.26%) ▼|LRCX269.23-1.64 (-0.61%) ▼|MA567.75-5.52 (-0.96%) ▼|MCD248.56-4.22 (-1.67%) ▼|MDLZ62.36+0.26 (+0.42%) ▲|MDT92.60-1.15 (-1.23%) ▼|META673.31+3.07 (+0.46%) ▲|MMM162.65-2.02 (-1.23%) ▼|MO70.10+0.29 (+0.42%) ▲|MRK144.91+1.12 (+0.78%) ▲|MS202.42-3.86 (-1.87%) ▼|MSFT490.30-6.82 (-1.37%) ▼|MU926.55-1.05 (-0.11%) ▼|NEE80.37-0.70 (-0.86%) ▼|NFLX76.41-1.49 (-1.91%) ▼|NKE35.78-0.44 (-1.21%) ▼|NOW139.82-2.08 (-1.47%) ▼|NVDA213.90+1.73 (+0.82%) ▲|ORCL143.16+2.81 (+2.00%) ▲|PEP134.34-1.16 (-0.86%) ▼|PFE27.46-0.09 (-0.33%) ▼|PG147.02+0.35 (+0.24%) ▲|PLTR174.34+1.78 (+1.03%) ▲|PM191.71-2.40 (-1.24%) ▼|QCOM184.84-2.96 (-1.58%) ▼|RTX196.83+1.33 (+0.68%) ▲|SBUX97.34+0.76 (+0.79%) ▲|SCHW105.16-2.63 (-2.44%) ▼|SO86.23+0.28 (+0.33%) ▲|SPG202.94-1.16 (-0.57%) ▼|T25.86-0.86 (-3.22%) ▼|TMO648.43+7.04 (+1.10%) ▲|TMUS176.26-4.21 (-2.33%) ▼|TSLA358.08+1.50 (+0.42%) ▲|TXN260.67-2.76 (-1.05%) ▼|UBER70.97-0.46 (-0.64%) ▼|UNH375.26-0.67 (-0.18%) ▼|UNP280.92-3.07 (-1.08%) ▼|UPS98.77-3.58 (-3.50%) ▼|USB59.73-2.49 (-4.00%) ▼|V370.93-4.69 (-1.25%) ▼|VZ49.76-1.69 (-3.28%) ▼|WFC87.05-2.67 (-2.98%) ▼|WMT107.50-0.59 (-0.55%) ▼|XOM163.32-6.00 (-3.54%) ▼|

23.1 C

New York

Thursday, September 17, 2026

First Lithium Minerals Announces Commencement of New LIFE Offering

Orex Minerals Announces Adoption of Semi-Annual Reporting Framework

Crown Capital Announces TSXV Listing and Voluntarily Delisting from TSX

Tag: officer

WBBA Broadband Development Congress Shanghai 2025 | Smarter Infrastructure: Converging AI and Broadband

SHANGHAI, June 23, 2025 /PRNewswire/ -- The World Broadband Association (WBBA) successfully convened the 2025 Broadband Development Congress in Shanghai, spotlighting the theme: "Smarter...

Antonio Filosa Announces New Stellantis Leadership Team on First Day as CEO

AMSTERDAM, June 23, 2025 /PRNewswire/ -- Antonio Filosa today takes up the role as Chief Executive Officer of Stellantis N.V. and announces his new...

New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential

Press Release

Galapagos Appoints Aaron Cox as Chief Financial Officer

Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership

Fondaction’s share price set at $16.70

Highlights of the fiscal year ended May 31, 2025 Share value of $16.70, down $0.03 from the value established following the 6-month period ended November 30, 2024...

Everest Medicines Announces Official Publication of the Specifications for Antimicrobial Susceptibility Testing of Eravacycline (2025)

SHANGHAI, June 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing,...

PFMCrypto Launches Revolutionary XRP Mining Contracts, Igniting Market Enthusiasm

PFMCrypto’s bold move has attracted the attention of cryptocurrency enthusiasts worldwide with the launch of a revolutionary XRP mining model—potentially marking a turning point for the digital asset. As XRP continues to consolidate, analysts suggest that a breakout may be imminent

PFMCrypto’s bold move has attracted the attention of cryptocurrency enthusiasts worldwide with the launch of a revolutionary XRP mining model—potentially marking a turning point for the digital asset. As XRP continues to consolidate, analysts suggest that a breakout may be imminent

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data...

Bagsværd, Denmark, 22 June 2025 – Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis from emicizumab treatment, without a washout period or Mim8 loading dose, was well-tolerated with no safety concerns in adults and adolescents living with haemophilia A, with or without inhibitors¹. Additionally, a FRONTIER5 Patient-Reported Outcomes (PROs) assessment found the Mim8 pen-injector easy to use, with an overall strong user preference for the pen-injector compared to the previous emicizumab injection system^2,3. The results were presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington, D.C.

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsOfficer

First Lithium Minerals Announces Commencement of New LIFE Offering

Orex Minerals Announces Adoption of Semi-Annual Reporting Framework

Crown Capital Announces TSXV Listing and Voluntarily Delisting from TSX

Tag: officer

WBBA Broadband Development Congress Shanghai 2025 | Smarter Infrastructure: Converging AI and Broadband

Antonio Filosa Announces New Stellantis Leadership Team on First Day as CEO

New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential

Galapagos Appoints Aaron Cox as Chief Financial Officer

Fondaction’s share price set at $16.70

Everest Medicines Announces Official Publication of the Specifications for Antimicrobial Susceptibility Testing of Eravacycline (2025)

PFMCrypto Launches Revolutionary XRP Mining Contracts, Igniting Market Enthusiasm

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data...

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

Big Tech Execs Play Soldier—What a Joke

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us